Sera Prognostics Inc

NASDAQ:SERA USA Medical Devices
Market Cap
$71.87 Million
Market Cap Rank
#21113 Global
#7594 in USA
Share Price
$1.91
Change (1 day)
-4.98%
52-Week Range
$1.49 - $4.14
All Time High
$13.04
About

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel bl… Read more

Sera Prognostics Inc (SERA) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.079x

Based on the latest financial reports, Sera Prognostics Inc (SERA) has a cash flow conversion efficiency ratio of -0.079x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.48 Million) by net assets ($82.18 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sera Prognostics Inc - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Sera Prognostics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Sera Prognostics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sera Prognostics Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Sera Prognostics Inc (2019–2024)

The table below shows the annual cash flow conversion efficiency of Sera Prognostics Inc from 2019 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $47.80 Million $-14.19 Million -0.297x +23.41%
2023-12-31 $70.16 Million $-27.19 Million -0.388x -10.79%
2022-12-31 $98.94 Million $-34.61 Million -0.350x -53.21%
2021-12-31 $138.56 Million $-31.64 Million -0.228x +96.02%
2020-12-31 $2.94 Million $-16.87 Million -5.737x -225.29%
2019-12-31 $10.96 Million $-19.32 Million -1.764x --